Thu.Sep 15, 2022

article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database.

article thumbnail

ABAC Therapeutics embarks on research for antibiotics to combat drug resistant gram-negative bacteria

AuroBlog - Aurous Healthcare Clinical Trials blog

ABAC Therapeutics, together with the artificial intelligence (AI) company Peptris and the Foundation for Neglected Disease Research (FNDR), with scientific support from Medicines for Malaria Venture (MMV), has collaborated to optimize a new chemical structure that has shown effectiveness against gram-negative bacteria, the current threat to public health.

Bacteria 154
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

API landscape in 2022: Drivers and solutions for small molecules

Pharmaceutical Technology

Research by GlobalData (Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition) shows that containment facilities are in high demand as the use of cytotoxic drugs continues to grow. The same research also shows that all the top small molecule API contract manufacturing organisations (CMOs) increased the number of containment facilities they owned between 2019 and 2021, while at the same time, many companies decreased non-containment, small molecule manufacturing.

article thumbnail

Opinion: 6 tactics to make artificial intelligence work on the frontlines

STAT News

Artificial intelligence is a transformative tool in the workplace — except when it isn’t. For top managers, state-of-the art AI tools are a no-brainer: in theory, they increase revenues, decrease costs, and improve the quality of products and services. But in the wild, it’s often just the opposite for frontline employees who actually need to integrate these tools into their daily work.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

University of Birmingham scientists detect new drug target for CNS injury

Pharmaceutical Technology

Scientists at the University of Birmingham in the UK have detected a possible drug target for the treatment of neurological ailments, such as Alzheimer’s disease (AD), and boosting nerve regeneration in central nervous system (CNS) injuries. This research is part of ongoing work analysing the signalling pathways underlying ‘programmed cell death’, which is observed in long-term neurological conditions as well as spinal cord or optic nerve injuries.

Scientist 130
article thumbnail

High rents outpace federal disability payments, leaving many homeless

NPR Health - Shots

Supplemental Security Income, a federal program meant to be a financial floor for people unable to work, hasn't kept pace with inflation. Many recipients are homeless, unable to save for an apartment.

121
121

More Trending

article thumbnail

Opinion: Congress needs to preserve seniors’ access to pharmacist care

STAT News

Covid-19 demonstrated how quickly the United States can mobilize to produce and distribute new tests, vaccines, and treatments for a previously unknown virus. The pandemic also highlighted significant inequalities and gaps in its health care system, with many rural and underserved urban areas lacking sufficient access to care. Amid those two realities, pharmacists played a central role in providing access to testing, vaccination, and treatment, especially for older and socioeconomically vulnerab

article thumbnail

Leading injectables (commercial dose) companies in contract marketing

Pharmaceutical Technology

The increase in the production of biological drugs such as vaccines, gene and cell therapies, and monoclonal antibodies, is increasing the volume of injectable drug products in the global healthcare market. The surge in diseases is spurring demand for constructive treatment solutions, which is expected to boost the sales of injectable pharmaceutical companies.

Marketing 130
article thumbnail

‘How do we support each other?’: A physician and ethicist on the difficult decisions doctors now face in abortion care

STAT News

As new abortion bans are enacted around the country, physicians working with pregnant patients are facing potential ethical and legal dilemmas. Even if a law allows for an exception when the life of the mother is at risk, there are no clear answers for doctors trying to decide if and when they can act. Matthew Wynia is a physician who has spent decades focused on medical ethics, including roles at the helm of the ​​Ethics Institute at the American Medical Association and the Ethics

Doctors 105
article thumbnail

Leading commercial packaging companies in contract marketing

Pharmaceutical Technology

Packaging plays a vital role in maintaining the quality, safety, user-friendliness and marketability of drugs and other pharmaceutical products. The pharmaceutical industry requires specialised and cost-effective commercial packaging solutions to improve efficiency and preserve the integrity of products through the entire supply chain, from primary packaging and labelling to shipping, delivery, storage and distribution to end users.

Packaging 130
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Medicare provides insufficient access to opioid addiction treatment, report finds

STAT News

Medicare is vastly underserving older Americans with opioid use disorder, with only 18% of enrollees with the diagnosis receiving recommended medication treatment, according to a new federal oversight report. The report, from the U.S. health department’s Office of Inspector General, also found that more than 50,000 Part D beneficiaries overdosed on opioids in 2021, whether painkillers or illicit drugs.

Drugs 105
article thumbnail

Leading API chemical companies in contract marketing

Pharmaceutical Technology

The growing demand from customers and pressures from global competitors have increased the significance of active pharmaceutical ingredients (API) chemical companies in the pharmaceutical industry supply chain. Various factors have contributed to the need and growth of API chemical suppliers such as rising healthcare expenditure, increasing disposable incomes, growing geriatric population, increasing incidence of chronic diseases, patent expiration of blockbuster drugs, increased consumption of

Marketing 130
article thumbnail

Novartis probed by Swiss authorities over ‘unlawful’ patent use

pharmaphorum

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.” The Swiss Competition Commission (COMCO) arrived unexpectedly at Novartis at dawn on Tuesday morning, to gather information on an unidentified dermatology drug, as part of a wider investigation into the drugmaker by the European Commission.

article thumbnail

4 ways the world messed up its pandemic response — and 3 fixes to do better next time

NPR Health - Shots

A new report from the Lancet Commission sums up the many mistakes that have been made and offers proposals for a more effective global strategy if and when another pandemic should strike.

105
105
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

STAT+: Swiss authorities raid Novartis offices seeking info on patents used to block rivals

STAT News

The Swiss Competition Commission has begun an investigation into Novartis over the possible unlawful use of a patent to block competitors for some of its medicines, the latest instance in which European authorities have probed drug companies for antitrust infractions. Earlier this week, the Swiss agency conducted a dawn raid on Novartis headquarters in Basel, Switzerland, seeking information about efforts the company allegedly made to protect a drug for an unspecified skin treatment.

Sales 98
article thumbnail

It’s time to tackle the gender health gap with technology

pharmaphorum

The potential for technology to transform the way we deliver healthcare is nothing new. We’ve been discussing it for some years now and are starting to see more widespread adoption, particularly post-pandemic. But the area where I believe technology can have the greatest impact – and where there is still plenty of work to do – is women’s health. Today, women spend around a quarter of their lives in poor health or disability, compared with one fifth for men.

Doctors 96
article thumbnail

These 3 startups are trying to improve diversity in clinical trials, a challenge experts say will take more than just tech

STAT News

A host of health tech startups and companies are advertising their apps and platforms as key solutions to improving diversity in clinical trials, promising to help researchers improve their outreach, enrollment, and retention — what one researcher calls a “modern-day gold rush.” The Power platform focuses on breaking down medical jargon and helping users connect with trial sponsors nearby.

article thumbnail

AN APPROACH TO THE HAIR FALL & HAIR GROWTH MANAGEMENT

Pharma Tutor

AN APPROACH TO THE HAIR FALL & HAIR GROWTH MANAGEMENT. About Authors Avdesh Thassu. MPharm (Nat. Chem.); MBA(Mkt.). Associate Vice President. Global Regulatory Affairs, Emami Limited, 7044455199. athassu@hotmail.com. Chandra Mohan Nandi. MSc. (Organic Chem.). Deputy Manager, Global Regulatory Affairs, Emami Limited, 9051706947 chandramohannandi@yahoo.in. admin.

94
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

STAT+: Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug

STAT News

In a victory for Gilead Sciences, Brazilian antitrust authorities dismissed a complaint filed by several advocacy groups that alleged the company charged “abusive” prices for a hepatitis C treatment. In their filing , which was made in 2019, the groups argued that “unlawful conduct” carried out by Gilead had hurt the public interest, because its prices led the government to ration the Sovaldi medication.

Drugs 98
article thumbnail

Mallinckrodt’s long haul with terlipressin in US ends in approval

pharmaphorum

Mallinckrodt has finally claimed FDA approval for terlipressin as a treatment for hepatorenal syndrome (HRS), after manufacturing problems scuppered an earlier attempt. Terlipressin – now given the brand name Terlivaz – has become the first and only FDA-approved treatment for adults with HRS who are experiencing a rapid reduction in kidney function, a life threatening condition, getting the green light well ahead of the FDA’s deadline date of 9 December.

article thumbnail

Pharma leans into telehealth, Flo’s anonymous mode arrives, and clever digital deals

STAT News

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

article thumbnail

canSERV rolls out cancer research services across Europe

Pharma Times

European wide research infrastructures, oncology experts and patient associations link up to combat cancer

Research 101
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

STAT+: Pharmalittle: Swiss authorities probe Novartis over patent used to block rivals; Medicare underserves older Americans with opioid use disorder

STAT News

Rise and shine, everyone, another busy day is on the way. This morning is getting off to a fabulous start, though, as a delightfully cool breeze and warm sun are enveloping the subdued Pharmalot campus, where the official mascot is snoozing nearby. As always, we are quaffing some cups of stimulation — chocolate raspberry is our choice du jour — and assembling some tidbits for your pleasure.

article thumbnail

Research positions Nordic Bioscience’s PRO-C6 as next-generation biomarker

Pharma Times

The PRO-C6 biomarker assay has been transferred to Roche Diagnostics for further analysis

Research 101
article thumbnail

Controversial harm reduction strategies appear to slow drug deaths

NPR Health - Shots

U.S. public health experts are studying Canada's harm reduction programs which include supervised injection sites and legally prescribed drugs that people with addiction can use to get high.

Drugs 75
article thumbnail

Novo Nordisk and Microsoft partner to boost AI in drug discovery

Drug Discovery World

A new partnership will bring together Microsoft’s computational services, cloud and artificial intelligence (AI) and Novo Nordisk’s drug discovery, development and data science capabilities. Through the agreement, Microsoft will provide AI technology, foundational science models and expertise and work alongside Novo Nordisk’s data scientists and domain experts to accelerate the company’s R&D.

Drugs 52
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Senators grill top health agencies on the U.S. response to monkeypox

NPR Health - Shots

In the first congressional hearing on monkeypox, federal officials were criticized for being slow to act, and struggling to apply the lessons of the pandemic to the current outbreak.

63
article thumbnail

Australian CRO Avance buys C3 Research to support sponsors as programs advance

Outsourcing Pharma

Australian CRO Avance Clinical has expanded in North America by acquiring C3 Research Associates, positioning it to continue supporting sponsors as they move into later-phase studies that need US sites.

article thumbnail

What to Look for in a Pharmaceutical Packaging Company

Pharma Packaging Solutions

Pharmaceutical packaging companies play a critical role in the pharmaceutical industry. They are largely responsible for keeping pharmaceutical products safe and secure as they travel through the supply chain. Thus, choosing a packaging company to partner with is a very important decision. Here are a few things to consider when selecting a pharmaceutical contract manufacturing company.

article thumbnail

New treatment option for Scottish kidney transplant patients

Drug Discovery World

The Scottish Medicines Consortium (SMC) has ruled Idefirix (imlifidase) clinically and cost-effective in highly sensitised adult patients prior to kidney transplant from a deceased donor. . The recommendation, which follows a positive ruling by the National Institute of Health and Care Excellence (NICE), marks an important milestone as highly sensitised patients are currently highly unlikely to receive a compatible kidney transplant.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.